|
Volumn 27, Issue 6, 1998, Pages 1376-1378
|
Editorial response: Antifungal prophylaxis with weekly fluconazole for patients with AIDS
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
FLUCONAZOLE;
PROTEINASE INHIBITOR;
VIRUS RNA;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
AGED;
CANDIDA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION PREVENTION;
LYMPHOCYTE COUNT;
MAJOR CLINICAL STUDY;
MUCOCUTANEOUS CANDIDIASIS;
MULTICENTER STUDY;
MYCOSIS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
THRUSH;
TOPICAL DRUG ADMINISTRATION;
AIDS RELATED COMPLEX;
CANDIDIASIS;
CHEMOPROPHYLAXIS;
DRUG ADMINISTRATION;
MICROBIOLOGY;
NOTE;
SURVIVAL;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIFUNGAL AGENTS;
CANDIDIASIS;
CHEMOPREVENTION;
DRUG ADMINISTRATION SCHEDULE;
FLUCONAZOLE;
HUMANS;
MYCOSES;
SURVIVAL ANALYSIS;
|
EID: 0032246465
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/515017 Document Type: Editorial |
Times cited : (7)
|
References (38)
|